NCT07514169
- Conditions
- Large B-Cell Lymphoma (LBCL)
- Locations
-
- Ruijin Hospital Shanghai, China
Clinical trial condition
Large B-Cell Lymphoma (LBCL)
Explore clinical trials studying Large B-Cell Lymphoma (LBCL). Study availability and eligibility vary by location and protocol.
13 public trials
4 recruiting studies
Large B-Cell Lymphoma (LBCL) trial results
NCT07361224
- Conditions
- Large B-Cell Lymphoma (LBCL)
- Locations
-
- Sourasky Medical Center Tel Aviv, Israel
Recruiting
Real World Practice With Academic Anti CD19 CAR-T Cell Therapy in Relapse/Refractory B-cell Lymphoma
NCT07524816
- Conditions
- Large B-Cell Lymphoma (LBCL)
- Locations
-
- NN Alexandrov National Cancer Centre of Belarus Lyasny, Minsk Oblast, Belarus
NCT04661020
- Conditions
- Large B-Cell Lymphoma (LBCL)
- Locations
-
- The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Not yet recruiting
Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy
NCT07842198
- Conditions
- Agranulocytosis, Blood Protein Disorders, Cardiovascular Diseases, +21 more
- Locations
-
- Zealand University Hospital Roskilde, Vælg Venligst Region, Denmark
Not yet recruiting
A Phase I/II Trial of CT1190B in Patients With Relapsed/Refractory Large B-Cell Lymphoma
NCT07823829
- Conditions
- Large B-Cell Lymphoma (LBCL)
- Locations
-
- Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
- Shanghai Tongji Hospital Shanghai, Shanghai Municipality, China
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology 编辑译文 段落对照 Hubei, Wuhan, China
Not yet recruiting
Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma
NCT07774234
- Conditions
- Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, Immune System Diseases, +10 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07717177
- Conditions
- Large B-Cell Lymphoma (LBCL)
- Locations
-
- Ruijin Hospital Shanghai, China
Not yet recruiting
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL
NCT07594899
- Conditions
- Large B-Cell Lymphoma (LBCL)
- Locations
-
- Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Not yet recruiting
Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS
NCT07567014
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- NYU Langone Health Perlmutter Cancer Center - Sunset Park Brooklyn, New York, United States
- NYU Langone Health Perlmutter Cancer Center - Manhattan Manhattan, New York, United States
- NYU Langone Health - Long Island Mineola, New York, United States